Federal health agencies asked for an immediate pause of Johnson & Johnson’s single-dose coronavirus vaccine.
In a joint statement Tuesday, the CDC and FDA said it was investigating clots and reduced platelet counts in six women post-vaccination. This happened within two weeks of the injection. The women were between the ages of 18 and 48. One of the recipients passed away, and another is in critical condition.
More than 6.8 million doses of the J&J vaccine have been administered in the U.S.
NJ’s Governor, Phil Murphy stated all J&J vaccine appointments will be put on hold or cancelled.
IMPORTANT VACCINE UPDATE:— Governor Phil Murphy (@GovMurphy) April 13, 2021
💉 J&J vaccine appointments will be cancelled or put on hold at all New Jersey vaccination sites until further notice
💉 @NJDeptofHealth will work with all vaccination sites to make arrangements for the administration of an alternative 2-dose vaccine https://t.co/p19v7WF9HL
Pennsylvania Governor Tom Wolf also stated the state will pause the distribution of the Johnson & Johnson vaccine.
Pennsylvania is following the @CDCgov and @US_FDA recommendation to pause the use of the Johnson & Johnson vaccine.— Governor Tom Wolf (@GovernorTomWolf) April 13, 2021
We're taking this step out of an abundance of caution until @CDCgov and @US_FDA can review the six cases of rare blood clots that have occurred.
If you received the Johnson & Johnson vaccine and are experiencing severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination it is recommended to contact your health care provider. If three weeks have passed and you have not developed any side effects the risk of an adverse reaction is unlikely but it is important to continue to monitor yourself for symptoms.
To read more click here.